INMUNE BIO INC. Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares
INMUNE BIO INC. (INMB) reported Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares of 5.54 million shares for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares · last filed 2024-05-09
- INMUNE BIO INC. incremental common shares attributable to dilutive effect of contingently issuable shares for the quarter ending 2024-03-31 was 5.54M shares, a 0.48% increase year-over-year.
- INMUNE BIO INC. incremental common shares attributable to dilutive effect of contingently issuable shares for the quarter ending 2023-03-31 was 5.52M shares, a 11.65% increase year-over-year.
- INMUNE BIO INC. incremental common shares attributable to dilutive effect of contingently issuable shares for the quarter ending 2022-03-31 was 4.94M shares, a 14.56% decline year-over-year.
- INMUNE BIO INC. incremental common shares attributable to dilutive effect of contingently issuable shares for the quarter ending 2021-03-31 was 5.78M shares, a 13.92% increase year-over-year.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 3 month | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 6 month | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 6 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 9 month | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 12 month |
|---|---|---|---|---|---|
| 2024-03-31 | 5.54M shares 10-Q · filed 2024-05-09 | ||||
| 2023-09-30 | 5.58M shares 10-Q · filed 2023-11-01 | ||||
| 2023-06-30 | 5.58B shares 10-Q · filed 2023-08-07 | ||||
| 2023-03-31 | 5.52M shares 10-Q · filed 2024-05-09 | ||||
| 2022-09-30 | 4.93M shares 10-Q · filed 2023-11-01 | ||||
| 2022-06-30 | 4.93B shares 10-Q · filed 2023-08-07 | 4.93M shares 10-Q · filed 2022-08-03 | |||
| 2022-03-31 | 4.94M shares 10-Q · filed 2023-05-03 | ||||
| 2021-09-30 | 4.18M shares 10-Q · filed 2022-11-02 | ||||
| 2021-06-30 | 3.99M shares 10-Q · filed 2022-08-03 | 3.99M shares 10-Q · filed 2021-08-04 | |||
| 2021-03-31 | 5.78M shares 10-Q · filed 2022-05-05 | ||||
| 2020-09-30 | 5.41M shares 10-Q · filed 2021-11-03 | ||||
| 2020-06-30 | 5.09M shares 10-Q · filed 2021-08-04 | ||||
| 2020-03-31 | 5.08M shares 10-Q · filed 2021-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |